Semler Scientific (NASDAQ:SMLR) Releases Earnings Results, Beats Expectations By $0.35 EPS

Semler Scientific (NASDAQ:SMLR) announced its quarterly earnings data on Monday. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.37 by $0.35, Zacks reports. The firm had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.93%.

Semler Scientific Stock Down 4.5 %

NASDAQ:SMLR traded down $1.82 on Thursday, reaching $38.29. 120,368 shares of the company’s stock traded hands, compared to its average volume of 191,931. The firm has a market cap of $267.72 million, a PE ratio of 19.57 and a beta of 0.92. The stock has a 50-day simple moving average of $26.37 and a 200-day simple moving average of $28.81. Semler Scientific has a 12 month low of $20.88 and a 12 month high of $53.38.

Insider Buying and Selling

In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total value of $283,500.00. Following the transaction, the chief executive officer now directly owns 60,220 shares of the company’s stock, valued at approximately $1,707,237. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 30.20% of the stock is currently owned by company insiders.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.